Tapewire

NYSE · USD

AORT

ARTIVION, INC.

Export transactions ↓
Tapewire entity
4767
SEC CIK
0000784199
Parsed reports
700

Last 12 months

Inside the activity.

0 purchase rows · 64 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025024
Dec 202506
Jan 202600
Feb 2026012
Mar 2026013
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202604
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2023 Filed Mar 1, 2023 23:32 UTC
Maier Dennis BSVP, Operations
SaleCommon Stock 1,348 $12.94 $17,440.42
Disclosure

SEC source: 0000784199-23-000046 · wf-form4_167771351849025.xml · nonDerivative · entry 2

Maier Dennis B · CIK 0001742150 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,100

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:27 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
SaleCommon Stock 1,161 $12.94 $15,021.02
Disclosure

SEC source: 0000784199-23-000044 · wf-form4_167771320949974.xml · nonDerivative · entry 4

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,321

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:27 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
SaleCommon Stock 1,176 $12.94 $15,215.09
Disclosure

SEC source: 0000784199-23-000044 · wf-form4_167771320949974.xml · nonDerivative · entry 2

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,042

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:22 UTC
Getz Matthew AVP, Human Resources
SaleCommon Stock 722 $12.94 $9,341.24
Disclosure

SEC source: 0000784199-23-000042 · wf-form4_167771291630936.xml · nonDerivative · entry 4

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,128

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:22 UTC
Getz Matthew AVP, Human Resources
SaleCommon Stock 878 $12.94 $11,359.56
Disclosure

SEC source: 0000784199-23-000042 · wf-form4_167771291630936.xml · nonDerivative · entry 2

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,610

F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:52 UTC
Horton AmyVP, Chief Accounting Officer
GrantCommon Stock 4,240 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000060 · wf-form4_167771474864823.xml · nonDerivative · entry 3

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,784

F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:52 UTC
Horton AmyVP, Chief Accounting Officer
GrantCommon Stock 2,356 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000060 · wf-form4_167771474864823.xml · nonDerivative · entry 1

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,291

F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:49 UTC
LEE DAVID ASHLEYExecutive VP, COO & CFO
GrantCommon Stock 10,122 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000058 · wf-form4_167771458039755.xml · nonDerivative · entry 3

LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,641

F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:49 UTC
LEE DAVID ASHLEYExecutive VP, COO & CFO
GrantCommon Stock 4,713 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000058 · wf-form4_167771458039755.xml · nonDerivative · entry 1

LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 337,011

F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:46 UTC
Holloway Jean FSVP, General Counsel
GrantCommon Stock 7,756 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000056 · wf-form4_167771439541045.xml · nonDerivative · entry 3

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,758

F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:46 UTC
Holloway Jean FSVP, General Counsel
GrantCommon Stock 3,770 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000056 · wf-form4_167771439541045.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,968

F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:44 UTC
Davis John ESenior VP, Global Sales
GrantCommon Stock 7,630 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000054 · wf-form4_167771425072902.xml · nonDerivative · entry 3

Davis John E · CIK 0001653206 · Senior VP, Global Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,399

F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:44 UTC
Davis John ESenior VP, Global Sales
GrantCommon Stock 3,770 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000054 · wf-form4_167771425072902.xml · nonDerivative · entry 1

Davis John E · CIK 0001653206 · Senior VP, Global Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,954

F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:41 UTC GrantCommon Stock 4,240 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000052 · wf-form4_167771408921807.xml · nonDerivative · entry 3

Maney Rochelle L. · CIK 0001850597 · VP, Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,257

F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:41 UTC GrantCommon Stock 2,356 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000052 · wf-form4_167771408921807.xml · nonDerivative · entry 1

Maney Rochelle L. · CIK 0001850597 · VP, Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,895

F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:39 UTC
GREEN ANDREW MVP Regulatory
GrantCommon Stock 4,662 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000050 · wf-form4_167771394730114.xml · nonDerivative · entry 3

GREEN ANDREW M · CIK 0001191000 · VP Regulatory

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,971

F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:39 UTC
GREEN ANDREW MVP Regulatory
GrantCommon Stock 2,356 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000050 · wf-form4_167771394730114.xml · nonDerivative · entry 1

GREEN ANDREW M · CIK 0001191000 · VP Regulatory

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,187

F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:36 UTC
Mackin James PPresident & CEO
GrantCommon Stock 42,148 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000048 · wf-form4_167771379285071.xml · nonDerivative · entry 3

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 550,037

F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:36 UTC
Mackin James PPresident & CEO
GrantCommon Stock 28,282 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000048 · wf-form4_167771379285071.xml · nonDerivative · entry 1

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 520,534

F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:32 UTC
Maier Dennis BSVP, Operations
GrantCommon Stock 6,318 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000046 · wf-form4_167771351849025.xml · nonDerivative · entry 3

Maier Dennis B · CIK 0001742150 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,418

F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:32 UTC
Maier Dennis BSVP, Operations
GrantCommon Stock 3,770 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000046 · wf-form4_167771351849025.xml · nonDerivative · entry 1

Maier Dennis B · CIK 0001742150 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,448

F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:27 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
GrantCommon Stock 7,440 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000044 · wf-form4_167771320949974.xml · nonDerivative · entry 3

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,482

F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:27 UTC
Stanton Marshall S.SVP, Clinical & MD Affair
GrantCommon Stock 3,770 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000044 · wf-form4_167771320949974.xml · nonDerivative · entry 1

Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,218

F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:22 UTC
Getz Matthew AVP, Human Resources
GrantCommon Stock 4,240 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000042 · wf-form4_167771291630936.xml · nonDerivative · entry 3

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,850

F3 · shares: Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date.

Read SEC document
February 23, 2023 Filed Mar 1, 2023 23:22 UTC
Getz Matthew AVP, Human Resources
GrantCommon Stock 2,356 $0.00 $0.00
Disclosure

SEC source: 0000784199-23-000042 · wf-form4_167771291630936.xml · nonDerivative · entry 1

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,488

F1 · shares: Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:52 UTC
Getz Matthew AVP, Human Resources
Tax withholdingCommon Stock 282 $13.96 $3,936.72
Disclosure

SEC source: 0000784199-23-000034 · wf-form4_167698752571151.xml · nonDerivative · entry 3

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,132

F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:52 UTC
Getz Matthew AVP, Human Resources
Tax withholdingCommon Stock 1,125 $13.96 $15,705.00
Disclosure

SEC source: 0000784199-23-000034 · wf-form4_167698752571151.xml · nonDerivative · entry 2

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,414

F2 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:49 UTC
Holloway Jean FSVP, General Counsel
Tax withholdingCommon Stock 341 $13.96 $4,760.36
Disclosure

SEC source: 0000784199-23-000032 · wf-form4_167698735388013.xml · nonDerivative · entry 4

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,198

F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:49 UTC
Holloway Jean FSVP, General Counsel
Tax withholdingCommon Stock 1,359 $13.96 $18,971.64
Disclosure

SEC source: 0000784199-23-000032 · wf-form4_167698735388013.xml · nonDerivative · entry 3

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,539

F2 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:40 UTC
LEE DAVID ASHLEYExecutive VP, COO & CFO
Tax withholdingCommon Stock 526 $13.96 $7,342.96
Disclosure

SEC source: 0000784199-23-000028 · wf-form4_167698682715871.xml · nonDerivative · entry 4

LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,298

F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:40 UTC
LEE DAVID ASHLEYExecutive VP, COO & CFO
Tax withholdingCommon Stock 2,104 $13.96 $29,371.84
Disclosure

SEC source: 0000784199-23-000028 · wf-form4_167698682715871.xml · nonDerivative · entry 3

LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,824

F2 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:36 UTC
Maier Dennis BSVP, Operations
Tax withholdingCommon Stock 282 $13.96 $3,936.72
Disclosure

SEC source: 0000784199-23-000026 · wf-form4_167698656653147.xml · nonDerivative · entry 3

Maier Dennis B · CIK 0001742150 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,678

F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:36 UTC
Maier Dennis BSVP, Operations
Tax withholdingCommon Stock 1,125 $13.96 $15,705.00
Disclosure

SEC source: 0000784199-23-000026 · wf-form4_167698656653147.xml · nonDerivative · entry 2

Maier Dennis B · CIK 0001742150 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,960

F2 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:33 UTC
Horton AmyVP, Chief Accounting Officer
Tax withholdingCommon Stock 258 $13.96 $3,601.68
Disclosure

SEC source: 0000784199-23-000024 · wf-form4_167698637076316.xml · nonDerivative · entry 7

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,935

F4 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:33 UTC
Horton AmyVP, Chief Accounting Officer
Tax withholdingCommon Stock 1,107 $13.96 $15,453.72
Disclosure

SEC source: 0000784199-23-000024 · wf-form4_167698637076316.xml · nonDerivative · entry 6

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,193

F5 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:29 UTC
Mackin James PPresident & CEO
Tax withholdingCommon Stock 2,139 $13.96 $29,860.44
Disclosure

SEC source: 0000784199-23-000022 · wf-form4_167698613905019.xml · nonDerivative · entry 3

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 492,252

F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:29 UTC
Mackin James PPresident & CEO
Tax withholdingCommon Stock 8,553 $13.96 $119,399.88
Disclosure

SEC source: 0000784199-23-000022 · wf-form4_167698613905019.xml · nonDerivative · entry 2

Mackin James P · CIK 0001408470 · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 494,391

F2 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:26 UTC
Davis John ESenior VP, Global Sales
Tax withholdingCommon Stock 390 $13.96 $5,444.40
Disclosure

SEC source: 0000784199-23-000020 · wf-form4_167698597757603.xml · nonDerivative · entry 3

Davis John E · CIK 0001653206 · Senior VP, Global Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,184

F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 19, 2023 Filed Feb 21, 2023 13:26 UTC
Davis John ESenior VP, Global Sales
Tax withholdingCommon Stock 1,857 $13.96 $25,923.72
Disclosure

SEC source: 0000784199-23-000020 · wf-form4_167698597757603.xml · nonDerivative · entry 2

Davis John E · CIK 0001653206 · Senior VP, Global Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,574

F2 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:52 UTC
Getz Matthew AVP, Human Resources
Tax withholdingCommon Stock 363 $13.96 $5,067.48
Disclosure

SEC source: 0000784199-23-000034 · wf-form4_167698752571151.xml · nonDerivative · entry 1

Getz Matthew A · CIK 0001784253 · VP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,539

F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:46 UTC Tax withholdingCommon Stock 403 $13.96 $5,625.88
Disclosure

SEC source: 0000784199-23-000030 · wf-form4_167698718850083.xml · nonDerivative · entry 1

Maney Rochelle L. · CIK 0001850597 · VP, Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,539

F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:49 UTC
Holloway Jean FSVP, General Counsel
Tax withholdingCommon Stock 1,429 $13.96 $19,948.84
Disclosure

SEC source: 0000784199-23-000032 · wf-form4_167698735388013.xml · nonDerivative · entry 2

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,898

F2 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:49 UTC
Holloway Jean FSVP, General Counsel
Tax withholdingCommon Stock 556 $13.96 $7,761.76
Disclosure

SEC source: 0000784199-23-000032 · wf-form4_167698735388013.xml · nonDerivative · entry 1

Holloway Jean F · CIK 0001540065 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,327

F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:40 UTC
LEE DAVID ASHLEYExecutive VP, COO & CFO
Tax withholdingCommon Stock 635 $13.96 $8,864.60
Disclosure

SEC source: 0000784199-23-000028 · wf-form4_167698682715871.xml · nonDerivative · entry 1

LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 334,928

F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:36 UTC
Maier Dennis BSVP, Operations
Tax withholdingCommon Stock 380 $13.96 $5,304.80
Disclosure

SEC source: 0000784199-23-000026 · wf-form4_167698656653147.xml · nonDerivative · entry 1

Maier Dennis B · CIK 0001742150 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,085

F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:33 UTC
Horton AmyVP, Chief Accounting Officer
Exercise / conversionStock Options (Right to buy) · Derivative 3,000 $10.24 Strike: $10.24 $30,720.00
Disclosure

SEC source: 0000784199-23-000024 · wf-form4_167698637076316.xml · derivative · entry 9

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2023-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:33 UTC
Horton AmyVP, Chief Accounting Officer
Exercise / conversionStock Options (Right to buy) · Derivative 17,713 $10.24 Strike: $10.24 $181,381.12
Disclosure

SEC source: 0000784199-23-000024 · wf-form4_167698637076316.xml · derivative · entry 8

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Commn Stock · 17,713 shares

Expires 2023-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:33 UTC
Horton AmyVP, Chief Accounting Officer
Tax withholdingCommon Stock 363 $13.96 $5,067.48
Disclosure

SEC source: 0000784199-23-000024 · wf-form4_167698637076316.xml · nonDerivative · entry 5

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,300

F4 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:33 UTC
Horton AmyVP, Chief Accounting Officer
SaleCommon Stock 3,000 $14.13 $42,391.50
Disclosure

SEC source: 0000784199-23-000024 · wf-form4_167698637076316.xml · nonDerivative · entry 4

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,663

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2022

F3 · price: Reflects weighted average price. Range of prices were between $13.65 to $15.18. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full informationregarding the number of shares sold at each separate price

Read SEC document
February 17, 2023 Filed Feb 21, 2023 13:33 UTC
Horton AmyVP, Chief Accounting Officer
Exercise / conversionCommon Stock 3,000 $10.24 $30,720.00
Disclosure

SEC source: 0000784199-23-000024 · wf-form4_167698637076316.xml · nonDerivative · entry 3

Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,663

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2022

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.